Cell No. : Cell Name RCB4539 : MCS-1  update : 2022/03/03
Comment			Currently not ready.
Comment from the depositor
Terms and conditions
Remarks
Order Form
			Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
	Basic information	Expected time	Upon a request we will start preparation. Contact us: cellkitaku.brc@riken.jp
Reference information		Reference	4
		User's Publication	0

Top

Reference

16316  J C M Clark, C R Dass, P F M Choong  Development of chondrosarcoma animal models for assessment of adjuvant therapy  ANZ J Surg  2009  79(5):327-36  PubMed ID: 19566512   DOI: 10.1111/j.1445-2197.2009.04884.x

7513  Fujisawa N, Sato NL, Motoyama TI.  Inhibitory effects of transforming growth factor-beta1 pretreatment on experimental pulmonary metastasis of MCS-1 Chinese hamster mesenchymal chondrosarcoma cells.  Tohoku J Exp Med  1999  187(3):203-13  PubMed ID: 10458477   DOI: 10.1620/tjem.187.203

7516  Fujisawa N, Sato NL, Motoyama T.  Experimental pulmonary metastasis of Chinese hamster mesenchymal chondrosarcoma cell lines  Exp Anim  1995  43(5):761-4  PubMed ID: 7498344   DOI: 10.1538/expanim1978.43.5_761

7510  Fujisawa N, Sato NL, Motoyama T.  Establishment of clonal cell lines, with or without cartilage phenotypes, from a hamster mesenchymal chondrosarcoma.  Lab Anim Sci  1991  41(6):590-5  PubMed ID: 1667204

Top

User's Publication